Search Results - "Marchand, Mathilde"
-
1
Modelling recycling for the life cycle assessment of perovskite/silicon tandem modules
ISSN: 2105-0716, 2105-0716Published: EDP Sciences 2024Published in EPJ Photovoltaics (2024)“…With the massive growth of the global capacity of photovoltaics (PV) over the last decade, the PV waste is expected to increase dramatically in the near…”
Get full text
Journal Article -
2
Time-dependent population PK models of single-agent atezolizumab in patients with cancer
ISSN: 0344-5704, 1432-0843, 1432-0843Published: Berlin/Heidelberg Springer Berlin Heidelberg 01.08.2021Published in Cancer chemotherapy and pharmacology (01.08.2021)“…Purpose The time-varying clearance (CL) of the PD-L1 inhibitor atezolizumab was assessed on a population of 1519 cancer patients (primarily with non-small-cell…”
Get full text
Journal Article -
3
Application of Zinc-Based Metal-Organic Framework ZIF-8 on Paper: A Pilot Study on Visual Appearance and Effectiveness
ISSN: 2073-4360, 2073-4360Published: Switzerland MDPI AG 16.05.2025Published in Polymers (16.05.2025)“…Paper and cellulose-based materials are known for their sensitivity to humidity, which can create stresses among fibres and increase fragility. More…”
Get full text
Journal Article -
4
Early Decision Making in a Randomized Phase II Trial of Atezolizumab in Biliary Tract Cancer Using a Tumor Growth Inhibition-Survival Modeling Framework
ISSN: 1532-6535, 1532-6535Published: United States 01.09.2023Published in Clinical pharmacology and therapeutics (01.09.2023)“…We assess the longitudinal tumor growth inhibition (TGI) metrics and overall survival (OS) predictions applied to patients with advanced biliary tract cancer…”
Get more information
Journal Article -
5
Comparison of two‐stage and joint TGI‐OS modeling using data from six atezolizumab clinical studies in patients with metastatic non‐small cell lung cancer
ISSN: 2163-8306, 2163-8306Published: United States John Wiley & Sons, Inc 01.01.2024Published in CPT: pharmacometrics and systems pharmacology (01.01.2024)“…Two‐stage and joint modeling approaches are the two main approaches to investigate the link between longitudinal tumor size data and overall survival (OS) and…”
Get full text
Journal Article -
6
Tumor growth and overall survival modeling to support decision making in phase Ib/II trials: A comparison of the joint and two‐stage approaches
ISSN: 2163-8306, 2163-8306Published: United States John Wiley & Sons, Inc 01.06.2024Published in CPT: pharmacometrics and systems pharmacology (01.06.2024)“…Model‐based tumor growth inhibition (TGI) metrics are increasingly used to predict overall survival (OS) data in Phase III immunotherapy clinical trials…”
Get full text
Journal Article -
7
Prediction of overall survival in patients across solid tumors following atezolizumab treatments: A tumor growth inhibition–overall survival modeling framework
ISSN: 2163-8306, 2163-8306Published: United States John Wiley & Sons, Inc 01.10.2021Published in CPT: pharmacometrics and systems pharmacology (01.10.2021)“…The objectives of the study were to use tumor size data from 10 phase II/III atezolizumab studies across five solid tumor types to estimate tumor growth…”
Get full text
Journal Article -
8
Population Pharmacokinetics and Exposure‐Response of Subcutaneous Atezolizumab in Patients With Non‐Small Cell Lung Cancer
ISSN: 2163-8306, 2163-8306Published: United States John Wiley & Sons, Inc 01.04.2025Published in CPT: pharmacometrics and systems pharmacology (01.04.2025)“…ABSTRACT IMscin001 is a two‐part dose‐finding (Phase Ib) and ‐confirmation (Phase III) study to evaluate atezolizumab pharmacokinetics of subcutaneous (SC)…”
Get full text
Journal Article -
9
Validation of Hourly Global Horizontal Irradiance for Two Satellite-Derived Datasets in Northeast Iraq
ISSN: 2072-4292, 2072-4292Published: Basel MDPI AG 01.10.2018Published in Remote sensing (Basel, Switzerland) (01.10.2018)“…Several sectors need global horizontal irradiance (GHI) data for various purposes. However, the availability of a long-term time series of high quality in situ…”
Get full text
Journal Article -
10
Population pharmacokinetics and CD20 binding dynamics for mosunetuzumab in relapsed/refractory B‐cell non‐Hodgkin lymphoma
ISSN: 1752-8054, 1752-8062, 1752-8062Published: United States John Wiley & Sons, Inc 01.06.2024Published in Clinical and translational science (01.06.2024)“…Mosunetuzumab (Mosun) is a CD20xCD3 T‐cell engaging bispecific antibody that redirects T cells to eliminate malignant B cells. The approved step‐up dose…”
Get full text
Journal Article -
11
Psychological evaluation of candidates for the uterus transplantation French trial
ISSN: 0001-6349, 1600-0412, 1600-0412Published: United States John Wiley & Sons, Inc 01.03.2025Published in Acta obstetricia et gynecologica Scandinavica (01.03.2025)“…Introduction Since 2017, women with absolute uterine infertility due to Mayer‐Rokitansky‐Küster‐Hauser (MRKH) syndrome have been eligible to participate in a…”
Get full text
Journal Article -
12
Does climate help modeling COVID-19 risk and to what extent?
ISSN: 1932-6203, 1932-6203Published: United States Public Library of Science 07.09.2022Published in PloS one (07.09.2022)“…A growing number of studies suggest that climate may impact the spread of COVID-19. This hypothesis is supported by data from similar viral contagions, such as…”
Get full text
Journal Article -
13
Case Report: Post-Partum SARS-CoV-2 Infection After the First French Uterus Transplantation
ISSN: 2296-875X, 2296-875XPublished: Frontiers Media S.A 28.06.2022Published in Frontiers in surgery (28.06.2022)“…Absolute uterus factor infertility, whether congenital or acquired, renders the woman unable to carry a child. Although uterus transplantation (UTx) is being…”
Get full text
Journal Article -
14
First Longitudinal Analysis of the Immunological Mechanism at Play in Uterus Transplantation
ISSN: 2373-8731, 2373-8731Published: Hagerstown, MD Lippincott Williams & Wilkins 15.11.2024Published in Transplantation direct (15.11.2024)Get full text
Journal Article -
15
Tocilizumab-treated convalescent COVID-19 patients retain the cross-neutralization potential against SARS-CoV-2 variants
ISSN: 2589-0042, 2589-0042Published: United States Elsevier Inc 17.03.2023Published in iScience (17.03.2023)“…Although tocilizumab treatment in severe and critical coronavirus disease 2019 (COVID-19) patients has proven its efficacy at the clinical level, there is…”
Get full text
Journal Article -
16
Alternative dosing regimens for atezolizumab: an example of model-informed drug development in the postmarketing setting
ISSN: 0344-5704, 1432-0843, 1432-0843Published: Berlin/Heidelberg Springer Berlin Heidelberg 01.12.2019Published in Cancer chemotherapy and pharmacology (01.12.2019)“…Purpose To determine the exposure–response (ER) relationships between atezolizumab exposure and efficacy or safety in patients with advanced non-small cell…”
Get full text
Journal Article -
17
Tumor Growth Inhibition-Overall Survival Subgroup Analysis of Atezolizumab in the IMpower150 Study
ISSN: 1550-7416, 1550-7416Published: Springer 01.05.2022Published in The AAPS journal (01.05.2022)“…Longitudinal changes of tumor size or tumor-associated biomarkers have been receiving growing attention as early markers of treatment benefits. Tumor growth…”
Get full text
Journal Article -
18
Secondary alveolar bone grafting of clefts using bioactive glass 45S5: Long-term dental and periodontal status
ISSN: 0889-5406, 1097-6752, 1097-6752Published: United States Elsevier Inc 01.09.2025Published in American journal of orthodontics and dentofacial orthopedics (01.09.2025)“…Secondary alveolar bone grafting (SABG) restores the continuity of alveolar bone in orofacial clefts to establish a functional dental occlusion. Given the…”
Get full text
Journal Article -
19
Population pharmacokinetics of bevacizumab in cancer patients with external validation
ISSN: 0344-5704, 1432-0843, 1432-0843Published: Berlin/Heidelberg Springer Berlin Heidelberg 01.08.2016Published in Cancer chemotherapy and pharmacology (01.08.2016)“…Background Bevacizumab is approved for various cancers. This analysis aimed to comprehensively evaluate bevacizumab pharmacokinetics and the influence of…”
Get full text
Journal Article -
20
Modelling recycling for the life cycle assessment of perovskite/silicon tandem modules
ISSN: 2105-0716, 2105-0716Published: EDP sciences 2024Published in EPJ Photovoltaics (2024)“…With the massive growth of the global capacity of photovoltaics (PV) over the last decade, the PV waste is expected to increase dramatically in the near…”
Get full text
Journal Article